Replies to post #724087 on NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Then you should be super confident in taking my bet. Deal?

[XMaster2023]

Merck tried to get something for nothing, they were penny wise and pound foolish. Not only could they have extended their patent for 8 additional years, they could have cornered the market.

[AngeloFoca]

Merck could be sitting alone wondering what could have been.

It's exactly what I've been thinking... While we are all focused on Merck, it may well be someone we haven't even considered.



.

[Hopeforthefuture3]

If merck want nwbo they still have time to make a purchase. They (MRK)may not think the market for gbm (dcvax plus keytruda) is large enough for them in terms of revenue especially until approved by fda. Should we get approval by MHRA merck may take an interest as then better chance for fda/usa approval where revenue can be much higher
Merck has time, they could easily pay 10x current value or more just waiting to be sure of at least the first approval before committing to a purchase

[CrashOverride]

Gilead and Norvartis cannot manufacture CAR-T at scale without Northwest Biotherapeutics.

[dennisdave]

There is one thing I just dont understand. Where is Merck in all this? Why are they risking NWBO ending up becoming a runaway bride? Merck could have bought a call option placeholder in NWBO for as little as $300 million, which is the same amount for them as $ 20 is for you and me, by negotiating a first buyout for a certain PPS when certain milestones are being achieved. Or they could have already started a joint trial with NWBO with the same upfront payment under the condition that they have the right to use DCVAX in such a manner for the next 5 years blocking out all competition.

The point is no big pharma, Merck, has swooped in to block the competition in some creative way with a large pocket of cash this far. Why is that?